ArticleScience translational medicine2022

Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti-PD-1 immunotherapy.

Balamayooran Theivanthiran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.